Baader Bank Aktiengesellschaft’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Buy
+3,300
New +$1.79M 0.13% 130
2025
Q4
Sell
-9,000
Closed -$4.37M 604
2025
Q3
$4.37M Buy
9,000
+2,200
+32% +$1.02M 0.28% 66
2025
Q2
$2.76M Sell
6,800
-4,400
-39% -$1.84M 0.2% 104
2025
Q1
$5.57M Sell
11,200
-2,800
-20% -$1.52M 0.42% 70
2024
Q4
$7.28M Hold
14,000
0.48% 64
2024
Q3
$8.66M Hold
14,000
0.51% 62
2024
Q2
$7.74M Buy
+14,000
New +$8.02M 0.49% 58
2024
Q1
Sell
-10,500
Closed -$5.57M 399
2023
Q4
$5.57M Sell
10,500
-5,500
-34% -$2.66M 0.4% 57
2023
Q3
$8.1M Hold
16,000
0.55% 59
2023
Q2
$8.35M Hold
16,000
0.42% 99
2023
Q1
$9.22M Hold
16,000
0.47% 84
2022
Q4
$8.91M Buy
+16,000
New +$8.48M 0.43% 102

Other funds holding TMO

Baader Bank Aktiengesellschaft's TMO Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q1 2026, selling an estimated $1M and leaving 15,964 shares worth $7.83M. The position accounts for 0.61% of the portfolio, ranked #34.

Baader Bank Aktiengesellschaft first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $25M in Q1 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 15,964 shares of Thermo Fisher Scientific worth $7.83M as of Q1 2026.
  • Baader Bank Aktiengesellschaft sold 1,848 Thermo Fisher Scientific shares in Q1 2026, an estimated $1M.
  • Thermo Fisher Scientific made up 0.61% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #34 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Baader Bank Aktiengesellschaft's Thermo Fisher Scientific position peaked at $25M in Q1 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.